Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: Therapeutic and pharmacoeconomic considerations

Pinchas Cohen, Wayne Weng, Alan D. Rogol, Ron G. Rosenfeld, Anne Marie Kappelgaard, John Germak

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: Therapeutic and pharmacoeconomic considerations'. Together they form a unique fingerprint.

Medicine & Life Sciences